Maureen Miller

Maureen Miller

Maureen Miller

Prevention is the cure.
Adjunct Associate Professor
Epidemiology

Office/Address:

722 West 168th Street, 7th Floor
New York NY 10032
Phone:
646.303.1372
Website address: Email: Twitter:

Biography

Maureen Miller, PhD, is an infectious disease epidemiologist with training in medical anthropology. Her career straddles both the academic and public spheres. Dr. Miller has been involved in applied sexually transmitted infectious disease prevention research, programming and policy since the 1990s, has published a number of theoretical and research articles in peer reviewed scientific journals, and has a proven track record in attracting funding for the conduct of innovative research in resource poor settings. While a full-time professor at Columbia, she established Bed Stuy West Community Studies, a successful community-academic health research partnership in the largest Black community in North America. In addition to conducting research, Dr. Miller consults regularly with governments and non-governmental organizations around the world. Her completed projects range from the evaluation of an urban syringe exchange program that resulted in national program expansion, to the development of an analytic framework to evaluate international health programs in terms of gender health equity and human rights, to the creation of a strategic five year HIV prevention plan for New York City. Dr. Miller’s current projects harness the power of social media to bring research science on sexual health and disease prevention directly to the people who stand to benefit the most from this knowledge. She is exploring mechanisms to create independently funded and sustainable research models of large population samples using online information technology in innovative ways.

Topics

Education

PhD, 1997, Columbia University
MS, 1994, Columbia University
BA, 1992, Columbia University

Areas of Expertise

Research Design and Methods, Adolescent Health, Disparities / Inequalities in Health, Social Epidemiology, Women's Health, Public Health Education, Human Rights, HIV/AIDS, Sexually Transmitted Infections, Infectious Disease, Reproductive Rights, Sex Education and Safe Sex, Infectious Disease and Drug Use

Select Publications

Miller M, Liao Y, Wagner M, Corves K. HIV, the clustering of sexually transmitted infections (STIs) and sex risk among African American women who use drugs. Sexually Transmitted Diseases. 2008; 35(7):696-702.
Miller M, Neaigus A. Networks, resources and risk among women who use drugs. Social Science & Medicine 2001;52(6):967-978.
Miller M, Korves CT, Fernandez T. The social epidemiology of HIV transmission among African American women who use drugs and their social network members. AIDS Care. 2007;19(7):858-65.
Miller M, Liao Y, Manchikanti-Gomez A, Gaydos CA, DMellow D. Prevalence and incidence rates of Trichomonas vaginalis among African American women who use drugs in New York City: Associations and co-infections. Journal of Infectious Disease. 2008;197:503-9.
Miller M, Neaigus A. An economy of risk: resource acquisition strategies of inner city women who use drugs. International Journal of Drug Policy 2002; 13(5):399-408.
Gwizdala RA, Miller M, Bhat M, Vavagiakis P, Henry C, Neaigus A, Shi Q and Lowy FD. Staphylococcus aureus Among Drug Users: Identification of Hidden Networks. American Journal of Public Health. 2011;101:1268-76.
Miller M, Hagan E. Integrated biological behavioral surveillance in pandemic threat warning systems. Bulletin of the World Health Organization. 2017; 95:62-68. doi.org/10.2471/BLT.16.175984.
Lowy FD, Miller M. Staphylococcus aureus disease among drug users: understanding transmission dynamics and pathogenesis. Lancet Infectious Diseases 2002;2 :605-612.
Miller M, Eskild A, Mella I, Moi H, Magnus P. Gender differences in syringe exchange program use patterns in Oslo, Norway. Addiction 2001; 96(11):1639-51.
Miller M, Meyer L, Boufassa F, Persoz A, Sarr A, Robain M, Spira A and the SEROCO Study Group. Sexual behavior changes and protease inhibitor therapy. AIDS 2000;14 (4):F33-F39.

Back to Top